drugset / Trial / NCT06121518

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

NCT06121518

Phase 3 Completed 235 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

Timeline

Start
2023-07-31
Primary completion
2024-03-22
Completion
2024-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject D064 Unknown 20 mg
Subject D702 Unknown 1.25 mg